Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Abbott; AstraZenca; Biotronik; Boston Scientific Corporation; CSI; Daiichi-Sankyo/Elil Lilly and Company; Edwards Lifesciences; Medtronic; Pie Medical; PulseCath BV; Teleflex
- Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; Abbott; ACIST; Anteris; Approxima; Biotronik; Bolt Medical; Boston Scientific Corporation; CSI, Opsens; Daiichi-Sankyo/Elil Lilly and Company; JenaValve; Materialise; Medtronic; Pie Medical; PulseCath BV; Siemens Healthineers; Shockwave Medical; Teleflex